These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M. J Immunol; 2009 Sep 01; 183(5):3512-21. PubMed ID: 19648280 [Abstract] [Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G. Clin Rheumatol; 2003 Oct 01; 22(4-5):271-8. PubMed ID: 14576989 [Abstract] [Full Text] [Related]
4. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways. Thanei S, Vanhecke D, Trendelenburg M. Clin Immunol; 2015 Oct 01; 160(2):180-7. PubMed ID: 26148903 [Abstract] [Full Text] [Related]
5. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H. Arthritis Rheum; 2011 Aug 01; 63(8):2436-44. PubMed ID: 21506094 [Abstract] [Full Text] [Related]
6. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M. Ann N Y Acad Sci; 2005 Jun 01; 1050():193-200. PubMed ID: 16014534 [Abstract] [Full Text] [Related]
7. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J. Nephrol Dial Transplant; 2006 Nov 01; 21(11):3115-21. PubMed ID: 16877491 [Abstract] [Full Text] [Related]
8. C1q and systemic lupus erythematosus. Walport MJ, Davies KA, Botto M. Immunobiology; 1998 Aug 01; 199(2):265-85. PubMed ID: 9777411 [Abstract] [Full Text] [Related]
9. Anti C1q antibodies in cutaneous lupus erythematosus. Bălănescu E, Tănăsescu C, Bălănescu P, Olteanu R, Badea C, Petruţescu B, Grancea C, Vagu C, Bleotu C, Ruţă S, Ardeleanu C. Rom J Intern Med; 2010 Aug 01; 48(2):159-63. PubMed ID: 21428180 [Abstract] [Full Text] [Related]
10. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K. Scand J Rheumatol; 2007 Aug 01; 36(4):291-8. PubMed ID: 17763207 [Abstract] [Full Text] [Related]
11. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Vanhecke D, Roumenina LT, Wan H, Osthoff M, Schaller M, Trendelenburg M. Arthritis Rheum; 2012 Nov 01; 64(11):3706-14. PubMed ID: 22740328 [Abstract] [Full Text] [Related]
12. Relevance of anti-C1q autoantibodies to lupus nephritis. Tsirogianni A, Pipi E, Soufleros K. Ann N Y Acad Sci; 2009 Sep 01; 1173():243-51. PubMed ID: 19758158 [Abstract] [Full Text] [Related]
13. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis. Flierman R, Daha MR. Mol Immunol; 2007 Jan 01; 44(1-3):133-8. PubMed ID: 16870257 [Abstract] [Full Text] [Related]
14. Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Potlukova E, Kralikova P. Scand J Immunol; 2008 May 01; 67(5):423-30. PubMed ID: 18363591 [Abstract] [Full Text] [Related]
15. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven. Schaller M, Bigler C, Danner D, Ditzel HJ, Trendelenburg M. J Immunol; 2009 Dec 15; 183(12):8225-31. PubMed ID: 20007586 [Abstract] [Full Text] [Related]
16. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. O'Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW, van Kooten C, van der Vlag J, Berden JH, Daha MR. Mol Immunol; 2011 Oct 15; 49(1-2):75-83. PubMed ID: 21855148 [Abstract] [Full Text] [Related]
17. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC, Zhou B, Dong Y. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001 [Abstract] [Full Text] [Related]
18. Are anti-C1q antibodies different from other SLE autoantibodies? Pickering MC, Botto M. Nat Rev Rheumatol; 2010 Aug 13; 6(8):490-3. PubMed ID: 20421881 [Abstract] [Full Text] [Related]
19. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations. Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL. Semin Arthritis Rheum; 2012 Jun 13; 41(6):840-8. PubMed ID: 22177108 [Abstract] [Full Text] [Related]
20. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Ann Rheum Dis; 2005 Mar 13; 64(3):444-8. PubMed ID: 15286009 [Abstract] [Full Text] [Related] Page: [Next] [New Search]